Brokers Issue Forecasts for MariMed FY2026 Earnings

MariMed Inc. (OTCMKTS:MRMD) – Equities research analysts at Ventum Cap Mkts issued their FY2026 earnings estimates for shares of MariMed in a research report issued on Thursday, November 7th. Ventum Cap Mkts analyst A. Semple anticipates that the company will post earnings of $0.00 per share for the year. Ventum Cap Mkts currently has a “Strong-Buy” rating on the stock.

MariMed Trading Up 14.8 %

MariMed stock opened at $0.17 on Monday. The company’s fifty day simple moving average is $0.16 and its 200-day simple moving average is $0.19. The company has a quick ratio of 0.73, a current ratio of 1.55 and a debt-to-equity ratio of 1.01. MariMed has a 12 month low of $0.14 and a 12 month high of $0.39. The stock has a market cap of $63.33 million, a P/E ratio of -5.55 and a beta of 2.80.

MariMed Company Profile

MariMed Inc engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand.